SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-178712
Filing Date
2023-06-29
Accepted
2023-06-29 16:53:36
Documents
5
Effectiveness Date
2023-06-29

Document Format Files

Seq Description Document Type Size
1 S-8 d477380ds8.htm S-8 46615
2 EX-5.1 d477380dex51.htm EX-5.1 7923
3 EX-23.1 d477380dex231.htm EX-23.1 2313
4 EX-FILING FEES d477380dexfilingfees.htm EX-FILING FEES 16745
5 GRAPHIC g477380g0629011340006.jpg GRAPHIC 2410
  Complete submission text file 0001193125-23-178712.txt   78104
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273027 | Film No.: 231058164
SIC: 2834 Pharmaceutical Preparations